Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-17-009020
Filing Date
2017-02-14
Accepted
2017-02-14 17:27:02
Documents
1
Group Members
PETER KOLCHINSKYRA CAPITAL HEALTHCARE FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A v459117_sc13ga.htm SC 13G/A 51116
  Complete submission text file 0001144204-17-009020.txt   52883
Mailing Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116
Business Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116 617-778-2500
RA CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001346824 (see all company filings)

EIN.: 830406777 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 441-295-5950
Axovant Sciences Ltd. (Subject) CIK: 0001636050 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-88883 | Film No.: 17610631
SIC: 2834 Pharmaceutical Preparations